CO [China Cord Blood] SC 13D:
[]
CO [China Cord Blood] SC 13D/A: (Original Filing)
[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] [Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this May 8 , 2015 BETWEEN : (1) MAGNUM OPUS INTERNATIONAL HOLDINGS LIMITED , a company with limited liability incorporated in the British Virgin Islands Seller (the and (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its] []
CO [China Cord Blood] SC 13D/A: Execution Version PURCHASE A GREEMENT THIS PURCHASE A
[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] [Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this May 8 , 2015 BETWEEN : (1) MAGNUM OPUS INTERNATIONAL HOLDINGS LIMITED , a company with limited liability incorporated in the British Virgin Islands Seller (the and (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its] []
CO [China Cord Blood] SC 13D/A: (Original Filing)
[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] []
CO [China Cord Blood] 6-K: (Original Filing)
[China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife HONG KONG, China, May 8, 2015 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
CO [China Cord Blood] 6-K: China Cord Blood Corporation Receives Notice of Transactions
[China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife HONG KONG, China, May 8, 2015 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
CO [China Cord Blood] 6-K: (Original Filing)
[China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR HONG KONG, China, May 4, 2015 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
CO [China Cord Blood] 6-K: China Cord Blood Corporation Receives Notice of a
[China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR HONG KONG, China, May 4, 2015 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]
CO [China Cord Blood] SC 13D/A: (Original Filing)
[EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement BETWEEN: (1) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Notes Company (B) Ordinary Shares NYSE The Notes are convertible into ordinary shares of the Company, par value US$0.0001 per share (the " (C) The Seller intends to sell the Notes to the Purchaser,] [EXECUTION VERSION VOTING DEED THIS VOTING DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Trusts BG Shares Shares Purchaser Bio Garden, a company wholly owned by certain discretionary trusts (" (B) Mr. Kam holds 2,190,278 outstanding share options] [POWER OF ATTORNEY POWER OF ATTORNEY POWER OF ATTORNEY] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 2) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]
CO [China Cord Blood] SC 13D/A: EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement
[EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement BETWEEN: (1) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Notes Company (B) Ordinary Shares NYSE The Notes are convertible into ordinary shares of the Company, par value US$0.0001 per share (the " (C) The Seller intends to sell the Notes to the Purchaser,] [EXECUTION VERSION VOTING DEED THIS VOTING DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Trusts BG Shares Shares Purchaser Bio Garden, a company wholly owned by certain discretionary trusts (" (B) Mr. Kam holds 2,190,278 outstanding share options] [POWER OF ATTORNEY POWER OF ATTORNEY POWER OF ATTORNEY] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 2) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]
